Skip to main content
Caplight Logo









Xeptiva Therapeutics

Xeptiva Therapeutics

Private
MontevideoHealthcare & Life Scienceshttps://www.xeptiva.com/

Last Round

Seed

Oct 1, 2024

Total Funding Raised

$2.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Xeptiva Therapeutics is a biotechnology company that develops therapeutic vaccines for chronic inflammatory conditions in companion animals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

therapeutic vaccinesimmunotherapy for animalscompanion animal healthveterinary biotechveterinary therapeuticsanimal healthcanine arthritis treatmentcanine atopic dermatitisclinical stage biotechchronic inflammatory diseasedrug discoveryequine healthfeline healthbiomarker discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xeptiva Therapeutics Comparables

Compare Xeptiva Therapeutics with similar companies based on industry and business-model similarity.

Xeptiva Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zoetis Inc.
78%
Vetbiolix
78%
Boehringer Ingelheim
77%

Xeptiva Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 1, 2024

Key People

Founding team and executive leadership

Josefina Correa

Chief Executive Officer

Executive Team

Xeptiva Therapeutics Investors

Notable investors and investment history

Xeptiva Therapeutics investors
InvestorRounds
Zentynel Frontier InvestmentsSeed
Fen VenturesSeed
ND LatamSeed
iThink VCSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 117% MoM, reaching 3.1K.

  • Sep 21, 2024

    Grew 50% QoQ, from 6 to 9 employees.

Xeptiva Therapeutics Filings

Explore SEC and related filing metadata, where available.

Xeptiva Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Xeptiva Therapeutics's valuation, stock price, and market status.

Is Xeptiva Therapeutics a public or private company?

Xeptiva Therapeutics is a private company.

What is the current stock price of Xeptiva Therapeutics?

Xeptiva Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Xeptiva Therapeutics worth (valuation)?

Valuation information for Xeptiva Therapeutics is not publicly available.

Can I buy Xeptiva Therapeutics stock?

Xeptiva Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Xeptiva Therapeutics's last funding round?

Xeptiva Therapeutics's most recent funding round was Seed on October 1, 2024.

Who are the main investors in Xeptiva Therapeutics?

Key investors in Xeptiva Therapeutics include Zentynel Frontier Investments.

Will Xeptiva Therapeutics IPO soon?

No public IPO plans have been announced for Xeptiva Therapeutics.

How can I track Xeptiva Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Xeptiva Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontevideo
Employee Range12
Year Founded2021
Last FundingOct 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?